Cita APA (7a ed.)
Weller, S., Borland, J., Chen, S., Johnson, M., Savina, P., Wynne, B., . . . Piscitelli, S. (2014). Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment. European Journal of Clinical Pharmacology, 70(1), 29-36.
Cita Chicago Style (17a ed.)
Weller, Stephen, Julie Borland, Shuguang Chen, Mark Johnson, Paul Savina, Brian Wynne, Toshihiro Wajima, Amanda Peppercorn, y Stephen Piscitelli. "Pharmacokinetics of Dolutegravir in HIV-seronegative Subjects with Severe Renal Impairment." European Journal of Clinical Pharmacology 70, no. 1 (2014): 29-36.
Cita MLA (9a ed.)
Weller, Stephen, et al. "Pharmacokinetics of Dolutegravir in HIV-seronegative Subjects with Severe Renal Impairment." European Journal of Clinical Pharmacology, vol. 70, no. 1, 2014, pp. 29-36.
Precaución: Estas citas no son 100% exactas.